Monica Venere
Monica Venere
Assistant Professor, The Ohio State University
Verified email at
Cited by
Cited by
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis, LVF Vassiliou, P Karakaidos, P Zacharatos, A Kotsinas, ...
Nature 434 (7035), 907-913, 2005
Embryonic stem cell–specific microRNAs promote induced pluripotency
RL Judson, JE Babiarz, M Venere, R Blelloch
Nature biotechnology 27 (5), 459-461, 2009
53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer
RA DiTullio, TA Mochan, M Venere, J Bartkova, M Sehested, J Bartek, ...
Nature cell biology 4 (12), 998-1002, 2002
Generation of induced pluripotent stem cells in the absence of drug selection
R Blelloch, M Venere, J Yen, M Ramalho-Santos
Cell stem cell 1 (3), 245-247, 2007
SCFβTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response
A Peschiaroli, NV Dorrello, D Guardavaccaro, M Venere, T Halazonetis, ...
Molecular cell 23 (3), 319-329, 2006
Deadly teamwork: neural cancer stem cells and the tumor microenvironment
JD Lathia, JM Heddleston, M Venere, JN Rich
Cell stem cell 8 (5), 482-485, 2011
53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage
TA Mochan, M Venere, RA DiTullio Jr, TD Halazonetis
Cancer research 63 (24), 8586-8591, 2003
Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy ResistanceCancer Stem Cells: Targeting the Roots of Cancer
V Adorno-Cruz, G Kibria, X Liu, M Doherty, DJ Junk, D Guan, C Hubert, ...
Cancer research 75 (6), 924-929, 2015
53BP1, an activator of ATM in response to DNA damage
TA Mochan, M Venere, RA DiTullio Jr, TD Halazonetis
DNA repair 3 (8-9), 945-952, 2004
Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy
M Venere, HA Fine, PB Dirks, JN Rich
Glia 59 (8), 1148-1154, 2011
Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells
M Venere, P Hamerlik, Q Wu, RD Rasmussen, LA Song, A Vasanji, ...
Cell Death & Differentiation 21 (2), 258-269, 2014
Laminin alpha 2 enables glioblastoma stem cell growth
JD Lathia, M Li, PE Hall, J Gallagher, JS Hale, Q Wu, M Venere, E Levy, ...
Annals of neurology 72 (5), 766-778, 2012
The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma
M Venere, C Horbinski, JF Crish, X Jin, A Vasanji, J Major, AC Burrows, ...
Science translational medicine 7 (304), 304ra143-304ra143, 2015
Defective apoptosis and B‐cell lymphomas in mice with p53 point mutation at Ser 23
D MacPherson, J Kim, T Kim, BK Rhee, CTM van Oostrom, RA DiTullio Jr, ...
The EMBO journal 23 (18), 3689-3699, 2004
ATM signaling and 53BP1
O Zgheib, Y Huyen, RA DiTullio Jr, A Snyder, M Venere, ES Stavridi, ...
Radiotherapy and Oncology 76 (2), 119-122, 2005
The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains
J Bothos, MK Summers, M Venere, DM Scolnick, TD Halazonetis
Oncogene 22 (46), 7101-7107, 2003
Glioma stem cell maintenance: the role of the microenvironment
J M Heddleston, M Hitomi, M Venere, W A Flavahan, K Yang, Y Kim, ...
Current pharmaceutical design 17 (23), 2386-2401, 2011
Sox1 marks an activated neural stem/progenitor cell in the hippocampus
M Venere, YG Han, R Bell, JS Song, A Alvarez-Buylla, R Blelloch
Development 139 (21), 3938-3949, 2012
Valosin-Containing Protein Phosphorylation at Ser784 in Response to DNA Damage
M Livingstone, H Ruan, J Weiner, KR Clauser, P Strack, S Jin, A Williams, ...
Cancer research 65 (17), 7533-7540, 2005
The Rho guanine nucleotide exchange factor AKAP13 (BRX) is essential for cardiac development in mice
CM Mayers, J Wadell, K McLean, M Venere, M Malik, T Shibata, ...
Journal of Biological Chemistry 285 (16), 12344-12354, 2010
The system can't perform the operation now. Try again later.
Articles 1–20